| SIM0008-25MG
| InVivoSIM anti-human CD20 (Rituximab Biosimilar)
| 25 mg
| BioXCell
| Flow Cytometry; ELISA; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0307-100MG
| InVivoPlus anti-mouse CD16/CD32
| 100 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0011-5MG
| InVivoSIM anti-human C5 (Eculizumab Biosimilar)
| 5 mg
| BioXCell
| Inhibition of the activation of C5, Functional ass
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0213-50MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 50 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-100MG
| InVivoPlus polyclonal Armenian hamster IgG
| 100 mg
| BioXCell
|
|
| Armenian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BP0301-100MG
| InVivoPlus human IgG2 isotype control
| 100 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BP0050-50MG
| InVivoPlus anti-mouse IL-10R (CD210)
| 50 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0075-5MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 5 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0297-100MG
| InVivoPlus human IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BP0090-50MG
| InVivoPlus rat IgG2b I sotype control
| 50 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| RT0267-25MG
| ReadyTag anti-OVA
| 25 mg
| BioXCell
| ELISA
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0058-50MG
| InVivoPlus anti-mouse TNF?
| 50 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0032-5MG
| InVivoPlus mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0055-50MG
| InVivoPlus anti-mouse IFN?
| 50 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0265-1MG
| ReadyTag anti-GFP
| 1 mg
| BioXCell
| Western blot, Immunofluorescence
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0007-5MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 5 mg
| BioXCell
| VEGF neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0268-25MG
| ReadyTag anti-HA
| 25 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0013-1MG
| InVivoSIM anti-human IL-17A (Secukinumab Biosimilar)
| 1 mg
| BioXCell
| Functional assays, ELISA, Immunofluoresence, Immun
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0099-25MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 25 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0174-50MG
| InVivoPlus anti-mouse LAG-3
| 50 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0001-1-100MG
| InVivoPlus anti-mouse CD3?
| 100 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0310-25MG
| InVivoPlus anti-mouse VISTA
| 25 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0010-1MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 1 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0086-5MG
| InVivoPlus mouse IgG2b isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0117-25MG
| InVivoPlus anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0274-50MG
| InVivoPlus anti-mouse TIGIT
| 50 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0002-5MG
| InVivoSIM anti-human EGFR (Cetuximab Biosimilar)
| 5 mg
| BioXCell
| EGFR blockade; ELISA; Flow Cytometry
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0017-1-5MG
| InVivoPlus anti-mouse CD154 (CD40L)
| 5 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0031-25MG
| InVivoPlus anti-mouse OX40 (CD134)
| 25 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0005-50MG
| InVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
| 50 mg
| BioXCell
| Flow Cytometry; ELISA; Immunohistochemistry; Weste
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0264-1MG
| ReadyTag anti-GST
| 1 mg
| BioXCell
| Western blot
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0011-50MG
| InVivoSIM anti-human C5 (Eculizumab Biosimilar)
| 50 mg
| BioXCell
| Inhibition of the activation of C5, Functional ass
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0004-1-25MG
| InVivoPlus anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0003-50MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 50 mg
| BioXCell
| Blocking of PD-1/PD-L signaling; Flow Cytometry; I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0213-100MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 100 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0213-5MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 5 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0308-25MG
| InVivoPlus anti-rat CD4
| 25 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| SIM0007-25MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 25 mg
| BioXCell
| VEGF neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0308-5MG
| InVivoPlus anti-rat CD4
| 5 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0101-25MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0016-2-100MG
| InVivoPlus anti-mouse CD40
| 100 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0001-1MG
| InVivoSIM anti-human TNF? (Adalimumab Biosimilar)
| 1 mg
| BioXCell
| TNF? neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0008-1MG
| InVivoSIM anti-human CD20 (Rituximab Biosimilar)
| 1 mg
| BioXCell
| Flow Cytometry; ELISA; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0012-50MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 50 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0274-25MG
| InVivoPlus anti-mouse TIGIT
| 25 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0085-100MG
| InVivoPlus mouse IgG2a isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| CP146-1MG
| RecombiMAb anti-mouse CTLA-4 (CD152)
| 1 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0266-5MG
| ReadyTag anti-6-His
| 5 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| RT0266-1MG
| ReadyTag anti-6-His
| 1 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0088-100MG
| InVivoPlus rat IgG1 isotype control (anti-HRP)
| 100 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|